Skip to main content
Top
Published in: Neurological Sciences 2/2015

01-02-2015 | Original Article

Parkinson’s disease patients with pain suffer from more severe non-motor symptoms

Authors: Cheng-Jie Mao, Ju-Ping Chen, Xiao-Yi Zhang, Yi Chen, Si-Jiao Li, Jie Li, Kang-Ping Xiong, Wei-Dong Hu, Chun-Feng Liu

Published in: Neurological Sciences | Issue 2/2015

Login to get access

Abstract

Non-motor symptoms, including pain, depression, sleep disorder, and olfactory dysfunction, occur frequently in patients with Parkinson’s disease (PD), even before the onset of motor symptoms. Although studies have examined the correlation between pain and depression or sleep disorder in PD, few studies have investigated the correlation between pain and a range of other non-motor symptoms of PD. PD patients (n = 142) with or without pain were included in the study. PD severity was evaluated with the Unified Parkinson’s Disease Rating Scale (UPDRS) and the Hoehn and Yahr (H/Y) staging scale. Pain severity was analyzed with the Visual Analog Scale. The Hamilton Rating Scale for Depression (HRSD; 24 items), Montreal Cognitive Assessment Beijing Version (MoCA), and non-motor questionnaire (NMSQT) measured symptoms of depression, cognitive function, and non-motor symptoms. The incidence of pain was 47.9 % in patients with PD, most of whom had moderate pain levels. Patients with pain showed higher HRSD, UPDRS, H/Y, and NMSQT scores and lower MoCA scores compared to those of patients without pain. HRSD and NMSQT scores were closely related with pain (P < 0.001). Non-motor symptoms were more prominent in patients with pain compared to that of controls and PD patients without pain.
Literature
1.
go back to reference Lee MA, Walker RW, Hildreth TJ et al (2006) A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manage 32:462–469CrossRefPubMed Lee MA, Walker RW, Hildreth TJ et al (2006) A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manage 32:462–469CrossRefPubMed
2.
go back to reference Bair MJ, Robinson RL, Katon W et al (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433–2445CrossRefPubMed Bair MJ, Robinson RL, Katon W et al (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433–2445CrossRefPubMed
3.
go back to reference Hanagasi HA, Akat S, Gurvit H et al (2011) Pain is common in Parkinson’s disease. Clin Neurol Neurosurg 113:11–13CrossRefPubMed Hanagasi HA, Akat S, Gurvit H et al (2011) Pain is common in Parkinson’s disease. Clin Neurol Neurosurg 113:11–13CrossRefPubMed
4.
go back to reference Nieoullon A (2002) Dopamine and the regulation of cognition and attention. Prog Neurobiol 67:53–83CrossRefPubMed Nieoullon A (2002) Dopamine and the regulation of cognition and attention. Prog Neurobiol 67:53–83CrossRefPubMed
5.
go back to reference Roh JH, Kim BJ, Jang JH et al (2009) The relationship of pain and health-related quality of life in Korean patients with Parkinson’s disease. Acta Neurol Scand 119:397–403CrossRefPubMed Roh JH, Kim BJ, Jang JH et al (2009) The relationship of pain and health-related quality of life in Korean patients with Parkinson’s disease. Acta Neurol Scand 119:397–403CrossRefPubMed
6.
go back to reference Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed
7.
go back to reference Fahn S (2005) Does levodopa slow or hasten the rate of progression of Parkinson’s disease? J Neurol 252(Suppl 4):IV37–IV42PubMed Fahn S (2005) Does levodopa slow or hasten the rate of progression of Parkinson’s disease? J Neurol 252(Suppl 4):IV37–IV42PubMed
8.
go back to reference Hoehn MM, Yahr MD (2001) Parkinsonism: onset, progression, and mortality. Neurology 57:S11–S26PubMed Hoehn MM, Yahr MD (2001) Parkinsonism: onset, progression, and mortality. Neurology 57:S11–S26PubMed
10.
go back to reference Nie K, Zhang Y, Wang L et al (2012) A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson’s disease in China. J Clin Neurosci 19:1497–1500CrossRefPubMed Nie K, Zhang Y, Wang L et al (2012) A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson’s disease in China. J Clin Neurosci 19:1497–1500CrossRefPubMed
11.
go back to reference Chaudhuri KR, Martinez-Martin P, Schapira AH et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923CrossRefPubMed Chaudhuri KR, Martinez-Martin P, Schapira AH et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923CrossRefPubMed
12.
go back to reference Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:277–299CrossRefPubMed Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:277–299CrossRefPubMed
13.
go back to reference Smeding HM, Esselink RA, Schmand B et al (2005) Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD–a comparison of neuropsychological effects. J Neurol 252:176–182CrossRefPubMed Smeding HM, Esselink RA, Schmand B et al (2005) Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD–a comparison of neuropsychological effects. J Neurol 252:176–182CrossRefPubMed
15.
go back to reference Airavaara M, Harvey BK, Voutilainen MH et al (2012) CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice. Cell Transplant 21:1213–1223PubMedCentralCrossRefPubMed Airavaara M, Harvey BK, Voutilainen MH et al (2012) CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice. Cell Transplant 21:1213–1223PubMedCentralCrossRefPubMed
17.
go back to reference Santos-Garcia D, Abella-Corral J, Aneiros-Diaz A et al (2011) Pain in Parkinson’s disease: prevalence, characteristics, associated factors, and relation with other non motor symptoms, quality of life, autonomy, and caregiver burden. Rev Neurol 52:385–393PubMed Santos-Garcia D, Abella-Corral J, Aneiros-Diaz A et al (2011) Pain in Parkinson’s disease: prevalence, characteristics, associated factors, and relation with other non motor symptoms, quality of life, autonomy, and caregiver burden. Rev Neurol 52:385–393PubMed
18.
go back to reference Yong MH, Allen JC Jr, Prakash KM et al (2013) Differentiating non-motor symptoms in Parkinson’s disease from controls and hemifacial spasm. PLoS One 8:e49596PubMedCentralCrossRefPubMed Yong MH, Allen JC Jr, Prakash KM et al (2013) Differentiating non-motor symptoms in Parkinson’s disease from controls and hemifacial spasm. PLoS One 8:e49596PubMedCentralCrossRefPubMed
19.
go back to reference Jarcho JM, Mayer EA, Jiang ZK et al (2012) Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain 153:744–754CrossRefPubMed Jarcho JM, Mayer EA, Jiang ZK et al (2012) Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain 153:744–754CrossRefPubMed
20.
go back to reference Mylius V, Brebbermann J, Dohmann H et al (2011) Pain sensitivity and clinical progression in Parkinson’s disease. Mov Disord 26:2220–2225CrossRefPubMed Mylius V, Brebbermann J, Dohmann H et al (2011) Pain sensitivity and clinical progression in Parkinson’s disease. Mov Disord 26:2220–2225CrossRefPubMed
21.
go back to reference Nutt JG (2007) Continuous dopaminergic stimulation: is it the answer to the motor complications of Levodopa? Mov Disord 22:1–9CrossRefPubMed Nutt JG (2007) Continuous dopaminergic stimulation: is it the answer to the motor complications of Levodopa? Mov Disord 22:1–9CrossRefPubMed
22.
go back to reference Lim SY, Farrell MJ, Gibson SJ et al (2008) Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson’s disease? Mov Disord 23:1689–1695CrossRefPubMed Lim SY, Farrell MJ, Gibson SJ et al (2008) Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson’s disease? Mov Disord 23:1689–1695CrossRefPubMed
23.
go back to reference Romenets SR, Wolfson C, Galatas C et al (2012) Validation of the non-motor symptoms questionnaire (NMS-Quest). Parkinsonism Relat Disord 18:54–58CrossRefPubMed Romenets SR, Wolfson C, Galatas C et al (2012) Validation of the non-motor symptoms questionnaire (NMS-Quest). Parkinsonism Relat Disord 18:54–58CrossRefPubMed
24.
Metadata
Title
Parkinson’s disease patients with pain suffer from more severe non-motor symptoms
Authors
Cheng-Jie Mao
Ju-Ping Chen
Xiao-Yi Zhang
Yi Chen
Si-Jiao Li
Jie Li
Kang-Ping Xiong
Wei-Dong Hu
Chun-Feng Liu
Publication date
01-02-2015
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 2/2015
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-014-1942-y

Other articles of this Issue 2/2015

Neurological Sciences 2/2015 Go to the issue